Golden State Equity Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Golden State Equity Partners's LLY Position: Q1 2026 in Review
Golden State Equity Partners increased its Eli Lilly (LLY) stake by 110% in Q1 2026, buying an estimated $3.95M and bringing the position to 7,432 shares worth $6.84M. The position accounts for 0.52% of the portfolio, ranked #32.
Golden State Equity Partners first reported a position in LLY in Q4 2020 and has held it in 18 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Golden State Equity Partners held 7,432 shares of Eli Lilly worth $6.84M as of Q1 2026.
- Golden State Equity Partners bought 3,897 Eli Lilly shares in Q1 2026, an estimated $3.95M.
- Eli Lilly made up 0.52% of Golden State Equity Partners's portfolio in Q1 2026, its #32 holding.
- Golden State Equity Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 18 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.